hydroxyurea has been researched along with Tetralogy of Fallot in 1 studies
Tetralogy of Fallot: A combination of congenital heart defects consisting of four key features including VENTRICULAR SEPTAL DEFECTS; PULMONARY STENOSIS; RIGHT VENTRICULAR HYPERTROPHY; and a dextro-positioned AORTA. In this condition, blood from both ventricles (oxygen-rich and oxygen-poor) is pumped into the body often causing CYANOSIS.
Excerpt | Relevance | Reference |
---|---|---|
"Hydroxyurea seems to be an eddicient there alternative therapy for seconday polycythemia caused by incurable cyantic congenital heart disease." | 1.34 | [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report]. ( Békir, S; Ben Romdhane, N; Boussaada, R; Mechmèche, R, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boussaada, R | 1 |
Békir, S | 1 |
Ben Romdhane, N | 1 |
Mechmèche, R | 1 |
1 other study available for hydroxyurea and Tetralogy of Fallot
Article | Year |
---|---|
[Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
Topics: Adult; Erythrocytes; Follow-Up Studies; Heart Defects, Congenital; Heart Septal Defects, Ventricular | 2007 |